estriol has been researched along with Recrudescence in 25 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Excerpt | Relevance | Reference |
|---|---|---|
| " acidophili, estriol plus pelvic floor rehabilitation was effective and should be considered as first-line treatment for symptoms of urogenital aging in postmenopausal women." | 9.19 | Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women. ( Capobianco, G; Cherchi, PL; Dessole, M; Dessole, S; Meloni, GB; Wenger, JM, 2014) |
| " Animal models of multiple sclerosis have shown that the pregnancy hormone, estriol, can ameliorate disease and can cause an immune shift." | 9.10 | Treatment of multiple sclerosis with the pregnancy hormone estriol. ( Bouvier, S; Klutch, R; Liva, SM; Odesa, S; Pfeiffer, P; Sicotte, NL; Voskuhl, RR; Wu, TC, 2002) |
| "We enrolled 93 postmenopausal women with a history of recurrent urinary tract infections in a randomized, double-blind, placebo-controlled trial of a topically applied intravaginal estriol cream." | 9.07 | A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. ( Raz, R; Stamm, WE, 1993) |
| "A block randomized, double-blind, group-comparative, placebo-controlled study was conducted to assess the effect of oestriol on recurrent urinary tract infections in postmenopausal women." | 9.07 | Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. ( Andersen, P; Bodd, E; Gjersøe, E; Johannessen, GR; Johnsen, N; Kirkengen, AL, 1992) |
| " No significant differences in prophylactic antibiotic treatment with nitrofurantoin and norfloxacin, trimethoprim, sulfamethoxazole/trimethoprim, methamine hippurate, estriol, or cefaclor were found in clinical or microbiological cure in adult nonpregnant women with recurrent urinary tract infections (9 randomized control trials, 673 patients, relative risk ratio, 1." | 8.93 | Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis. ( Gregory, WT; Guran, LA; McDonagh, MS; Price, JR, 2016) |
| " acidophili, estriol plus pelvic floor rehabilitation was effective and should be considered as first-line treatment for symptoms of urogenital aging in postmenopausal women." | 5.19 | Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women. ( Capobianco, G; Cherchi, PL; Dessole, M; Dessole, S; Meloni, GB; Wenger, JM, 2014) |
| " Animal models of multiple sclerosis have shown that the pregnancy hormone, estriol, can ameliorate disease and can cause an immune shift." | 5.10 | Treatment of multiple sclerosis with the pregnancy hormone estriol. ( Bouvier, S; Klutch, R; Liva, SM; Odesa, S; Pfeiffer, P; Sicotte, NL; Voskuhl, RR; Wu, TC, 2002) |
| "The study goal was to report on the long-term results and effect of argon plasma coagulation (APC) surgery and topical estriol in patients with Osler's disease who had recurrent epistaxis." | 5.10 | Plasma surgery and topical estriol: effects on the nasal mucosa and long-term results in patients with Osler's disease. ( Bergler, W; Hörmann, K; Karl, H; Naim, R; Oulmi, J; Ramin, N; Sadick, H, 2003) |
| "To assess the efficacy of oral oestriol in the prevention of recurrent urinary tract infections in elderly women." | 5.08 | Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. ( Abbott, D; Benness, C; Cardozo, L, 1998) |
| "We enrolled 93 postmenopausal women with a history of recurrent urinary tract infections in a randomized, double-blind, placebo-controlled trial of a topically applied intravaginal estriol cream." | 5.07 | A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. ( Raz, R; Stamm, WE, 1993) |
| "A block randomized, double-blind, group-comparative, placebo-controlled study was conducted to assess the effect of oestriol on recurrent urinary tract infections in postmenopausal women." | 5.07 | Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. ( Andersen, P; Bodd, E; Gjersøe, E; Johannessen, GR; Johnsen, N; Kirkengen, AL, 1992) |
| " In a few small studies, thalidomide was shown to consistently improve severity and frequency of epistaxis and improve hemoglobin concentrations while decreasing the need for transfusion." | 4.98 | Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review. ( Clark, C; Halderman, AA; Invernizzi, R; Marple, BF; Poetker, DM; Reh, DD; Ryan, MW; Sindwani, R, 2018) |
| " No significant differences in prophylactic antibiotic treatment with nitrofurantoin and norfloxacin, trimethoprim, sulfamethoxazole/trimethoprim, methamine hippurate, estriol, or cefaclor were found in clinical or microbiological cure in adult nonpregnant women with recurrent urinary tract infections (9 randomized control trials, 673 patients, relative risk ratio, 1." | 4.93 | Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis. ( Gregory, WT; Guran, LA; McDonagh, MS; Price, JR, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (24.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halderman, AA | 1 |
| Ryan, MW | 1 |
| Clark, C | 1 |
| Sindwani, R | 1 |
| Reh, DD | 1 |
| Poetker, DM | 1 |
| Invernizzi, R | 1 |
| Marple, BF | 1 |
| Michala, L | 1 |
| Vlachopapadopoulou, E | 1 |
| Tsimaris, P | 1 |
| Papaioannou, G | 1 |
| Paisiou, A | 1 |
| Peristeri, I | 1 |
| Michalacos, S | 1 |
| Kitra, V | 1 |
| Seaberg, P | 1 |
| Jadoon-Khamash, E | 1 |
| Vegunta, S | 1 |
| Capobianco, G | 1 |
| Wenger, JM | 1 |
| Meloni, GB | 1 |
| Dessole, M | 1 |
| Cherchi, PL | 1 |
| Dessole, S | 1 |
| Price, JR | 1 |
| Guran, LA | 1 |
| Gregory, WT | 1 |
| McDonagh, MS | 1 |
| Gold, SM | 1 |
| Voskuhl, RR | 2 |
| Brostrøm, S | 1 |
| Lose, G | 1 |
| Sicotte, NL | 1 |
| Liva, SM | 1 |
| Klutch, R | 1 |
| Pfeiffer, P | 1 |
| Bouvier, S | 1 |
| Odesa, S | 1 |
| Wu, TC | 1 |
| Raz, R | 2 |
| Colodner, R | 1 |
| Rohana, Y | 1 |
| Battino, S | 1 |
| Rottensterich, E | 1 |
| Wasser, I | 1 |
| Stamm, W | 1 |
| Sadick, H | 2 |
| Naim, R | 1 |
| Ramin, N | 1 |
| Oulmi, J | 1 |
| Hörmann, K | 2 |
| Karl, H | 1 |
| Bergler, W | 2 |
| Hejlová, P | 1 |
| Zivný, J | 1 |
| Pinggera, GM | 1 |
| Feuchtner, G | 1 |
| Frauscher, F | 1 |
| Rehder, P | 1 |
| Strasser, H | 1 |
| Bartsch, G | 1 |
| Herwig, R | 1 |
| Tsuruta, D | 1 |
| Sowa, J | 1 |
| Kobayashi, H | 1 |
| Ishii, M | 1 |
| Stamm, WE | 1 |
| Svanborg, C | 1 |
| Sirakov, M | 1 |
| Veltova, L | 1 |
| Cardozo, L | 1 |
| Benness, C | 1 |
| Abbott, D | 1 |
| Gotte, K | 1 |
| Riedel, F | 1 |
| Thomassen, PA | 1 |
| Kirkengen, AL | 1 |
| Andersen, P | 1 |
| Gjersøe, E | 1 |
| Johannessen, GR | 1 |
| Johnsen, N | 1 |
| Bodd, E | 1 |
| Brandberg, A | 1 |
| Mellström, D | 1 |
| Samsioe, G | 1 |
| Bergström, H | 1 |
| Adlercreutz, H | 1 |
| Tikkanen, MJ | 1 |
| Wichmann, K | 1 |
| Svanborg, A | 1 |
| Anberg, A | 1 |
| Buyse, FG | 1 |
| Wormgoor, BH | 1 |
| Bernard, JT | 1 |
| Koudstaal, J | 1 |
| Sharoukhova, KS | 1 |
| Muraviova, NI | 1 |
| Kurockin, IF | 1 |
| Vishnyakova, VV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Combination Trial of Copaxone Plus Estriol in RRMS[NCT00451204] | Phase 2 | 158 participants (Actual) | Interventional | 2007-03-31 | Completed | ||
| Addressing Preference as a Patient-centered Outcome to Prevent Recurrent Urinary Tract Infection (rUTI) in Post-menopausal Women: a Cross-over Randomized Controlled Trial[NCT05723601] | Phase 4 | 24 participants (Anticipated) | Interventional | 2024-01-31 | Not yet recruiting | ||
| Probiotics and the Female Urinary Microbiome ProFUM Trial (Probiotics Effect on the Female Urinary Microbiome)[NCT03250208] | 8 participants (Actual) | Interventional | 2017-09-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A confirmed relapse was defined as new neurological symptoms or worsening of pre-existing symptoms, lasting at least 48 hours in a subject who had been neurologically stable or improving in the previous 30 days, accompanied by objective change in the neurological examination (worsening of 0.5 points on the EDSS or worsening by 1.0 or more points on the pyramidal, cerebellar, brainstem or visual functional system scores), not due to fatigue alone and not associated with fever or infection. (NCT00451204)
Timeframe: 12 months
| Intervention | relapses per year (Mean) |
|---|---|
| Estriol Capsules Plus Copaxone Injections | 0.25 |
| Placebo Capsules Plus Copaxone Injections | 0.48 |
A confirmed relapse was defined as new neurological symptoms or worsening of pre-existing symptoms, lasting at least 48 hours in a subject who had been neurologically stable or improving in the previous 30 days, accompanied by objective change in the neurological examination (worsening of 0.5 points on the EDSS or worsening by 1.0 or more points on the pyramidal, cerebellar, brainstem or visual functional system scores), not due to fatigue alone and not associated with fever or infection. (NCT00451204)
Timeframe: 24 months
| Intervention | relapses per year (Mean) |
|---|---|
| Estriol Capsules Plus Copaxone Injections | 0.25 |
| Placebo Capsules Plus Copaxone Injections | 0.37 |
(NCT00451204)
Timeframe: 24 months
| Intervention | probability of relapse at 24 months (Mean) |
|---|---|
| Estriol Capsules Plus Copaxone Injections | 33.3 |
| Placebo Capsules Plus Copaxone Injections | 42.9 |
Met all criteria for relapse except not confirmed to have increase in EDSS by an independent examiner. (NCT00451204)
Timeframe: 12 months
| Intervention | relapses per year (Mean) |
|---|---|
| Estriol Capsules Plus Copaxone Injections | 0.33 |
| Placebo Capsules Plus Copaxone Injections | 0.61 |
Met all criteria for relapse except not confirmed to have increase in EDSS by an independent examiner. (NCT00451204)
Timeframe: 24 months
| Intervention | relapses per year (Mean) |
|---|---|
| Estriol Capsules Plus Copaxone Injections | 0.32 |
| Placebo Capsules Plus Copaxone Injections | 0.46 |
(NCT00451204)
Timeframe: 24 months
| Intervention | probability of relapse event at 24 mo (Mean) |
|---|---|
| Estriol Capsules Plus Copaxone Injections | 40.5 |
| Placebo Capsules Plus Copaxone Injections | 46.9 |
4 reviews available for estriol and Recrudescence
| Article | Year |
|---|---|
Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review.
Topics: Administration, Oral; Administration, Topical; Angiogenesis Inhibitors; Epistaxis; Estriol; Estrogen | 2018 |
Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cefaclor; Estriol; Female; Humans; Nit | 2016 |
Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.
Topics: Clinical Trials as Topic; Disease Susceptibility; Estriol; Female; Humans; Incidence; Multiple Scler | 2016 |
[Oestrogen for prevention of recurrent urinary tract infections in postmenopausal women--a survey of a Cochrane review].
Topics: Administration, Intravaginal; Anti-Infective Agents, Urinary; Estradiol; Estriol; Estrogens; Evidenc | 2009 |
8 trials available for estriol and Recrudescence
| Article | Year |
|---|---|
Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women.
Topics: Administration, Intravaginal; Aged; Aging; Atrophy; Combined Modality Therapy; Electric Stimulation | 2014 |
Treatment of multiple sclerosis with the pregnancy hormone estriol.
Topics: Adolescent; Adult; Biomarkers; Cross-Over Studies; Estriol; Female; Humans; Hypersensitivity, Delaye | 2002 |
Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Estriol; Female; Humans; Middle Aged; Nitro | 2003 |
Plasma surgery and topical estriol: effects on the nasal mucosa and long-term results in patients with Osler's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Combined Modality Therapy; Epistaxis; Estriol; Fe | 2003 |
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Topics: Administration, Intravaginal; Double-Blind Method; Enterobacteriaceae; Estriol; Female; Follow-Up St | 1993 |
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Topics: Administration, Intravaginal; Double-Blind Method; Enterobacteriaceae; Estriol; Female; Follow-Up St | 1993 |
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Topics: Administration, Intravaginal; Double-Blind Method; Enterobacteriaceae; Estriol; Female; Follow-Up St | 1993 |
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Topics: Administration, Intravaginal; Double-Blind Method; Enterobacteriaceae; Estriol; Female; Follow-Up St | 1993 |
Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women.
Topics: Administration, Oral; Aged; Double-Blind Method; Estriol; Estrogen Replacement Therapy; Female; Huma | 1998 |
Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Argon; Chemotherapy, Adjuvant; Child; Drug Moni | 2002 |
Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Estriol; Female; Humans; Hydrogen-Ion Concentration; M | 1992 |
13 other studies available for estriol and Recrudescence
| Article | Year |
|---|---|
Resolution of Hematocolpos in Adolescents Affected with Graft vs Host Disease.
Topics: Adolescent; Bone Marrow Transplantation; Child; Estriol; Female; Graft vs Host Disease; Hematocolpos | 2018 |
Managing Recurrent Urinary Tract Infections in Postmenopausal Women.
Topics: Administration, Intravaginal; Aged, 80 and over; Estriol; Female; Humans; Postmenopause; Recurrence; | 2018 |
[Effect of vaginal estriol on urogenital symptoms in postmenopausal women].
Topics: Administration, Intravaginal; Aged; Estriol; Female; Humans; Middle Aged; Postmenopause; Recurrence; | 2004 |
Effects of local estrogen therapy on recurrent urinary tract infections in young females under oral contraceptives.
Topics: Administration, Intravaginal; Adolescent; Adult; Age Factors; Contraceptives, Oral; Estriol; Feasibi | 2005 |
Fixed food eruption caused by lactose identified after oral administration of four unrelated drugs.
Topics: Administration, Oral; Antihypertensive Agents; Azepines; Cilazapril; Dairy Products; Diagnosis, Diff | 2005 |
Resistance to urinary tract infection.
Topics: Bacterial Infections; Disease Susceptibility; Estriol; Female; Humans; Male; Recurrence; Sex Factors | 1993 |
[The treatment of synechia labiorum minorum].
Topics: Anesthesia, Local; Child; Child, Preschool; Estradiol Congeners; Estriol; Female; Follow-Up Studies; | 1997 |
Urinary bile acids during development of recurrent cholestasis of pregnancy.
Topics: Adult; Bile Acids and Salts; Cholestasis; Deoxycholic Acid; Dietary Fats; Estriol; Female; Humans; P | 1979 |
Low dose oral estriol treatment in elderly women with urogenital infections.
Topics: Administration, Oral; Aged; Aged, 80 and over; Estriol; Female; Genital Diseases, Female; Humans; La | 1987 |
Estriol in recurrent urinary tract infection in elderly women?
Topics: Aged; Aged, 80 and over; Estriol; Female; Humans; Male; Recurrence; Urinary Tract Infections | 1987 |
Recurrent jaundice in pregnancy. IV. Quantitative determination of urinary and biliary estrogens, including studies in pruritus gravidarum.
Topics: Bile; Cholestasis; Chromatography, Gas; Estradiol; Estriol; Estrogens; Estrone; Female; Gonadotropin | 1974 |
Anticoagulant therapy of patients with repeated placental infarction.
Topics: Adult; Anticoagulants; Cystinyl Aminopeptidase; Estriol; Female; Fetal Death; Fetal Diseases; Hepari | 1974 |
The study of the excretion of estrogens in patients with breast cancer treated with androgens.
Topics: Adult; Androgens; Breast Neoplasms; Castration; Estradiol; Estriol; Estrogens; Estrone; Female; Huma | 1972 |